Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

• James L Gulley,
• Julie R Brahmer,
• Pedro J Romero,
• Francesco M Marincola,
• Charles G Drake,
• Stefani Spranger,
• Lisa H Butterfield,
• Douglas G McNeel,
• Alessandra Cesano,
• Thomas F Gajewski,
• Howard L Kaufman,
• Bernard A Fox,
• Leisha A Emens,
• Mario Sznol,
• Tanja D de Gruijl,
• Daniel S Chen,
• Patrick Hwu,
• Paolo Antonio Ascierto,
• Walter J Urba,
• Jon M Wigginton,
• Robert O Dillman,
• Michael B Atkins,
• Kim A Margolin,
• Paul M Sondel,
• Michael T Lotze,
• Ana Carrizosa Anderson,
• Ernest C Borden,
• David Kaufman,
• Michael J Mastrangelo,
• Marcela V Maus,
• David R Parkinson,
• George J Weiner,
• Jeffrey S Weber,
• F Stephen Hodi Jr

Affiliations

James L Gulley

Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA

Julie R Brahmer

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA

Pedro J Romero

Novigenix, Epalinges, Switzerland

Francesco M Marincola

Aff8 grid.467063.00000000403974222Research, Sidra Medical and Research Center Doha Qatar

Charles G Drake

Department of Medicine, Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, New York, USA

Stefani Spranger

2Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA

Lisa H Butterfield

7Merck Research Laboratories, South San Francisco, CA, USA

Douglas G McNeel

Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA

Alessandra Cesano

Aff2 NanoString, Inc 500 Fairview Avenue North 98109 Seattle WA USA

Thomas F Gajewski

Pathology and Medicine, The University of Chicago Biological Sciences Division, Chicago, Illinois, USA

Howard L Kaufman

Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA

Bernard A Fox

Earle A Chiles Research Institute, Robert W Franz Cancer Center, Portland, Oregon, USA

Leisha A Emens

1 Ankyra Therapeutics, Cambridge, Massachusetts, USA

Mario Sznol

Yale University Yale Cancer Center, New Haven, Connecticut, USA

Tanja D de Gruijl

Department of Medical Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands

Daniel S Chen

Engenuity Life Sciences, Burlingame, California, USA

Patrick Hwu

Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Paolo Antonio Ascierto

3 Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, IRCCS Fondazione G. Pascale, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy

Walter J Urba

Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA

Jon M Wigginton

Aff2 grid.419971.3Bristol-Myers Squibb Princeton NJ USA

Robert O Dillman

Aff1 grid.414587.b0000000097556590Hoag Institute for Research and EducationHoag Hospital Newport Beach CA USA

Michael B Atkins

14 Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA

Kim A Margolin

City of Hope National Medical Center, Duarte, California, USA

Paul M Sondel

Department of Human Oncology, University of Wisconsin, Madison, Wisconsin, USA

Michael T Lotze

UPMC Hillman Cancer Center and University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Ana Carrizosa Anderson

3 The Gene Lay Institute of Immunology and Inflammation, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women`s Hospital, Boston, Massachusetts, USA

Ernest C Borden

5 University of Wisconsin Clinical Cancer Center, Madison, Wisconsin, USA

David Kaufman

Section of Allergy/Immunology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA

Michael J Mastrangelo

24 Thomas Jefferson Medical College, Philadelphia, Pennsylvania, USA

Marcela V Maus

Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA

David R Parkinson

26 ESSA Pharma Inc, Palo Alto, California, USA

George J Weiner

2Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA

Jeffrey S Weber

33 Laura and Isaac Perlmutter Comprehensive Cancer Center, NYU Langone Medical Center, New York, New York, USA

F Stephen Hodi Jr

16 Dana Farber Cancer Institute, Boston, Massachusetts, USA